Clinical Trial Update: Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating imaging characteristics of florbetapir F-18 in Alzheimer's disease, frontotemporal dementia, and normal controls, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Frontotemporal Dementia

Drugs mentioned

• Florbetapir F-18 (florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease, Frontotemporal Dementia | Phase 2 | Status: COMPLETED | Results posted: 2014-09-17